The Resource Assessing genomic sequencing information for health care decision making : workshop summary, Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy ; Sarah H. Beachy, Samuel G. Johnson, Adam C. Berger, and Steve Olson, rapporteurs ; Institute of Medicine of the National Academies

Assessing genomic sequencing information for health care decision making : workshop summary, Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy ; Sarah H. Beachy, Samuel G. Johnson, Adam C. Berger, and Steve Olson, rapporteurs ; Institute of Medicine of the National Academies

Label
Assessing genomic sequencing information for health care decision making : workshop summary
Title
Assessing genomic sequencing information for health care decision making
Title remainder
workshop summary
Statement of responsibility
Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy ; Sarah H. Beachy, Samuel G. Johnson, Adam C. Berger, and Steve Olson, rapporteurs ; Institute of Medicine of the National Academies
Creator
Contributor
Author
Issuing body
Subject
Genre
Language
eng
Summary
"Rapid advances in technology have lowered the cost of sequencing an individual's genome from the several billion dollars that it cost a decade ago to just a few thousand dollars today and have correspondingly greatly expanded the use of genomic information in medicine. Because of the lack of evidence available for assessing variants, evaluation bodies have made only a few recommendations for the use of genetic tests in health care. For example, organizations, such as the Evaluation of Genomic Applications in Practice and Prevention working group, have sought to set standards for the kinds of evaluations needed to make population-level health decisions. However, due to insufficient evidence, it has been challenging to recommend the use of a genetic test. An additional challenge to using large-scale sequencing in the clinic is that it may uncover "secondary," or "incidental," findings - genetic variants that have been associated with a disease but that are not necessarily related to the conditions that led to the decision to use genomic testing. Furthermore, as more genetic variants are associated with diseases, new information becomes available about genomic tests performed previously, which raises issues about how and whether to return this information to physicians and patients and also about who is responsible for the information. To help develop a better understanding of how genomic information is used for healthcare decision making, the Roundtable on Translating Genomic-Based Research for Health of the Institute of Medicine held a workshop in Washington, DC in February 2014. Stakeholders, including clinicians, researchers, patients, and government officials, discussed the issues related to the use of genomic information in medical practice. Assessing Genomic Sequencing Information for Health Care Decision Making is the summary of that workshop. This report compares and contrasts evidence evaluation processes for different clinical indications and discusses key challenges in the evidence evaluation process"--Publisher's description
Cataloging source
MMU
Dewey number
616/.042
Illustrations
illustrations
Index
no index present
LC call number
RB155
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://bibfra.me/vocab/relation/rapporteur
  • VeUaQOu8yVk
  • jETwvWfdzMU
  • iOqIckmEKMY
  • 77ZvP6No5U8
Label
Assessing genomic sequencing information for health care decision making : workshop summary, Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy ; Sarah H. Beachy, Samuel G. Johnson, Adam C. Berger, and Steve Olson, rapporteurs ; Institute of Medicine of the National Academies
Publication
Copyright
Bibliography note
Includes bibliographical references
http://library.link/vocab/branchCode
  • net
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Introduction -- How evidence is gathered and evaluated -- Patient care and health decisions -- The development of practice guidelines -- How insurers decide whether to pay for testing -- Addressing challenges
Control code
ocn888201733
Extent
1 online resource (xx, 105 pages)
Form of item
online
Isbn
9780309304955
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations
http://library.link/vocab/recordID
.b35441756
Specific material designation
remote
System control number
  • (OCoLC)888201733
  • pebcs0309304954

Library Locations

    • Deakin University Library - Geelong Waurn Ponds CampusBorrow it
      75 Pigdons Road, Waurn Ponds, Victoria, 3216, AU
      -38.195656 144.304955
Processing Feedback ...